Hosted on MSN1mon
FDA approves 'ketamine' nasal spray for depression — here's everything you need to know
For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone therapy for adults with treatment-resistant depression (TRD).
Hosted on MSN1mon
FDA Expands Approval of Esketamine for Depression
The FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an inadequate response to at least two oral antidepressants, maker Johnson ...
Philippine Daily Inquirer1mon
World’s first anti-depression nasal spray receives FDA approval
The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent version of ketamine. Esketamine should only provide rapid relief from depression symptoms until other ...